Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Clinical highlights in CLL

Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany
Clinical highlights in CLL ( Prof Clemens Wendtner - Klinikum Schwabing, Munich, Germany )
30 Sep 2013

A review of treatment approaches in CLL

Prof William Wierda - MD Anderson Cancer Center, Houston, Texas, USA
A review of treatment approaches in CLL ( Prof William Wierda - MD Anderson Cancer Center, Houston, Texas, USA )
30 Sep 2013

Overview of the FCR regimen

Prof William Wierda - MD Anderson Cancer Center, Houston, Texas, USA
Overview of the FCR regimen ( Prof William Wierda - MD Anderson Cancer Center, Houston, Texas, USA )
30 Sep 2013

TDM1 versus physicians choice in treatment in breast cancer

Dr Hans Wildiers - University Hospital Gasthuisberg, Belgium
TDM1 versus physicians choice in treatment in breast cancer ( Dr Hans Wildiers - University Hospital Gasthuisberg, Belgium )
30 Sep 2013

The State of Oncology 2013: a new report draws attention on disparities in cancer care

Prof Peter Boyle - International Prevention Research Institute
The State of Oncology 2013: a new report draws attention on disparities in cancer care ( Prof Peter Boyle - International Prevention Research Institute )
30 Sep 2013

Aspirin may act on blood platelets to improve survival in colon cancer patients

Dr Marlies Reimers - Leiden University Medical Center, Netherlands
Aspirin may act on blood platelets to improve survival in colon cancer patients ( Dr Marlies Reimers - Leiden University Medical Center, Netherlands )
30 Sep 2013

Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on prostate cancer screening from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
30 Sep 2013

Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer

Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK
Phase III trial, ICON6, shows cediranib improves survival in recurrent ovarian cancer ( Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK )
30 Sep 2013

Comment on primary site tumours from the ECC 2013 Scientific Co-Chair

Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy
Comment on primary site tumours from the ECC 2013 Scientific Co-Chair ( Prof Cora Sternberg - San Camillo and Forlanini Hospitals, Rome, Italy )
30 Sep 2013

Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients

Dr Marlies Reimers - Leiden University Medical Center, Netherlands
Research shows how aspirin may act on blood platelets to improve survival in colon cancer patients ( Dr Marlies Reimers - Leiden University Medical Center, Netherlands )
30 Sep 2013

ICON6 phase III trial shows cediranib improves survival in recurrent ovarian cancer

Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK
ICON6 phase III trial shows cediranib improves survival in recurrent ovarian cancer ( Prof Jonathan Ledermann - UCL Cancer Institute, University College London, UK )
30 Sep 2013

Overview of upcoming trials and possibility of new treatment approaches in CLL

Prof Wierda - MD Anderson Cancer Center, Houston, Texas, USA
Overview of upcoming trials and possibility of new treatment approaches in CLL ( Prof Wierda - MD Anderson Cancer Center, Houston, Texas, USA )
30 Sep 2013